in situ Hi-C4DNEXGPUBP1L
released
February 14th, 2022 at 6:57pm
Source Publication
Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia.
Zazhytska M, Kodra A, et al., Cell 2022
Properties
Experiment Type
Follows SOP
No
Biosample
Digestion Enzyme
Biosample Modifications
None
Biosample Treatments
SARS-Cov2, clinical isolate UAS/WA1/2020 treatment (100 PFU, 1d at 25°C)